(Q27687622)

English

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years

scientific article

Statements

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years. (English)
1 reference
S Walker
1 reference
J Burch
1 reference
C McKenna
1 reference
K Wright
1 reference
S Griffin
1 reference
N Woolacott
1 reference
May 2011
1 reference
15 Suppl 1
1 reference
13-21
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit